Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113351-113400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04439175
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)
PHASE2
Active, not recruiting
70 participants
Started: Feb 25, 2016 · Completed: Mar 19, 2026
6 conditions
1 sponsor
1 location
NCT02842424
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
PHASE4
Recruiting
70 participants
Started: Feb 25, 2016 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04439357
Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)
PHASE2
Active, not recruiting
4 participants
Started: Feb 25, 2016 · Completed: Dec 31, 2025
6 conditions
1 sponsor
1 location
NCT04439318
Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)
PHASE2
Active, not recruiting
50 participants
Started: Feb 25, 2016 · Completed: Dec 31, 2025
6 conditions
1 sponsor
1 location
NCT04439149
Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)
PHASE2
Active, not recruiting
24 participants
Started: Feb 25, 2016 · Completed: Nov 30, 2025
6 conditions
1 sponsor
1 location
NCT02713334
Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling
N/A
Active, not recruiting
495 participants
Started: Feb 25, 2016 · Completed: Feb 25, 2026
1 condition
1 sponsor
1 location
NCT02710734
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
PHASE2
Active, not recruiting
78 participants
Started: Feb 24, 2016 · Completed: Feb 28, 2034
1 condition
1 sponsor
4 locations
NCT06357988
Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)
PHASE2
Active, not recruiting
35 participants
Started: Feb 24, 2016 · Completed: Dec 31, 2026
6 conditions
1 sponsor
1 location
NCT02478099
MPDL3280A-treatment-IST-UMCG
PHASE2
Active, not recruiting
81 participants
Started: Feb 24, 2016 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT02453984
MPDL3280A-imaging-IST-UMCG
NA
Active, not recruiting
45 participants
Started: Feb 24, 2016 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Feb 23, 2016 · Completed: Jul 15, 2027
3 conditions
1 sponsor
5 locations
NCT02734290
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
PHASE1/PHASE2
Active, not recruiting
29 participants
Started: Feb 23, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT05169333
The Oxford Risk Factors And Non-Invasive Imaging Study
N/A
Recruiting
250,000 participants
Started: Feb 23, 2016 · Completed: Feb 28, 2030
2 conditions
7 sponsors
37 locations
NCT05049746
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
NA
Active, not recruiting
95 participants
Started: Feb 23, 2016 · Completed: Feb 2, 2027
20 conditions
1 sponsor
1 location
NCT02671435
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
PHASE1/PHASE2
Active, not recruiting
383 participants
Started: Feb 22, 2016 · Completed: Sep 1, 2025
1 condition
1 sponsor
49 locations
NCT02406729
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
PHASE3
Active, not recruiting
16,935 participants
Started: Feb 22, 2016 · Completed: Nov 30, 2024
1 condition
1 sponsor
17 locations
NCT02611089
Muscle Connective Tissue in Limb Development and Disease
N/A
Recruiting
150 participants
Started: Feb 20, 2016 · Completed: Aug 31, 2036
1 condition
4 sponsors
5 locations
NCT02689440
Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
PHASE2
Active, not recruiting
155 participants
Started: Feb 19, 2016 · Completed: Dec 31, 2040
2 conditions
2 sponsors
1 location
NCT04268901
VR to Reduce Pain/Anxiety During Painful Procedures
NA
Recruiting
700 participants
Started: Feb 19, 2016 · Completed: Dec 6, 2025
8 conditions
2 sponsors
1 location
NCT06596265
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
N/A
Recruiting
1,000 participants
Started: Feb 17, 2016 · Completed: Jun 17, 2028
6 conditions
3 sponsors
1 location
NCT05386615
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
N/A
Recruiting
200 participants
Started: Feb 16, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
6 locations
NCT03430492
Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience
N/A
Active, not recruiting
985 participants
Started: Feb 15, 2016 · Completed: Dec 31, 2025
1 condition
5 sponsors
4 locations
NCT02626312
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
PHASE1
Active, not recruiting
36 participants
Started: Feb 15, 2016 · Completed: Apr 28, 2026
4 conditions
2 sponsors
1 location
NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
PHASE1
Recruiting
22 participants
Started: Feb 12, 2016 · Completed: Dec 31, 2027
11 conditions
1 sponsor
1 location
NCT02453620
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
PHASE1
Active, not recruiting
57 participants
Started: Feb 12, 2016 · Completed: Sep 17, 2026
5 conditions
1 sponsor
5 locations
NCT02625961
Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
PHASE2
Active, not recruiting
320 participants
Started: Feb 10, 2016 · Completed: Oct 31, 2025
1 condition
1 sponsor
0 locations
NCT02610673
WiCS-LV Post Market Surveillance Registry
N/A
Active, not recruiting
100 participants
Started: Feb 8, 2016 · Completed: Jun 30, 2027
1 condition
1 sponsor
3 locations
NCT03934957
Hamburg City Health Study - a German Cohort Study
N/A
Recruiting
45,000 participants
Started: Feb 8, 2016 · Completed: Dec 31, 2028
10 conditions
3 sponsors
1 location
NCT02649387
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
PHASE2
Active, not recruiting
35 participants
Started: Feb 8, 2016 · Completed: Jan 15, 2026
4 conditions
1 sponsor
1 location
NCT03386981
Metabolic Profile of Bone in Professional Athletes
N/A
Recruiting
200 participants
Started: Feb 4, 2016 · Completed: Feb 4, 2027
2 conditions
1 sponsor
1 location
NCT02659241
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
EARLY_PHASE1
Active, not recruiting
38 participants
Started: Feb 4, 2016 · Completed: Dec 31, 2026
22 conditions
2 sponsors
8 locations
NCT03670472
Correction of Nonsense Mutations in Cystic Fibrosis
N/A
Recruiting
85 participants
Started: Feb 3, 2016 · Completed: Jan 31, 2030
1 condition
2 sponsors
8 locations
NCT03905668
Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future
N/A
Active, not recruiting
71 participants
Started: Feb 3, 2016 · Completed: Jul 31, 2028
2 conditions
5 sponsors
1 location
NCT02701153
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
NA
Recruiting
51 participants
Started: Feb 3, 2016 · Completed: Feb 3, 2027
1 condition
5 sponsors
1 location
NCT02861781
Collection of Human Metabolic Tissues
N/A
Recruiting
270 participants
Started: Feb 2, 2016 · Completed: Sep 30, 2028
3 conditions
1 sponsor
1 location
NCT02736656
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
PHASE3
Active, not recruiting
1,400 participants
Started: Feb 2, 2016 · Completed: Sep 30, 2026
1 condition
1 sponsor
16 locations
NCT02381561
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
PHASE1
Active, not recruiting
19 participants
Started: Feb 1, 2016 · Completed: Mar 14, 2026
41 conditions
1 sponsor
1 location
NCT03444259
Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
N/A
Active, not recruiting
1,001 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2029
8 conditions
2 sponsors
1 location
NCT02662907
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy
NA
Active, not recruiting
175 participants
Started: Feb 1, 2016 · Completed: Feb 2, 2027
1 condition
2 sponsors
1 location
NCT06830590
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
N/A
Recruiting
300 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT02625480
Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2
Active, not recruiting
95 participants
Started: Feb 1, 2016 · Completed: Feb 28, 2026
2 conditions
1 sponsor
30 locations
NCT03256201
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes
NA
Active, not recruiting
95 participants
Started: Feb 1, 2016 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT03057860
TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
N/A
Recruiting
2,800 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
3 locations
NCT06648044
Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
NA
Recruiting
310 participants
Started: Feb 1, 2016 · Completed: Feb 1, 2028
7 conditions
1 sponsor
1 location
NCT04571177
PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke
N/A
Active, not recruiting
20 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03521921
GIse Registry Of Transcatheter Treatment of Mitral Valve regurgitaTiOn (GIOTTO)
N/A
Active, not recruiting
1,500 participants
Started: Feb 1, 2016 · Completed: Sep 9, 2025
1 condition
1 sponsor
20 locations
NCT02849132
Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients
PHASE4
Active, not recruiting
800 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2025
2 conditions
8 sponsors
20 locations
NCT02730338
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
NA
Active, not recruiting
866 participants
Started: Jan 31, 2016 · Completed: Oct 31, 2026
1 condition
5 sponsors
18 locations
NCT02509286
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
PHASE3
Active, not recruiting
438 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2024
2 conditions
6 sponsors
30 locations
NCT03033771
Dragon Study Europe
NA
Active, not recruiting
27 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2029
1 condition
1 sponsor
4 locations
Previous
1
More pages
2265
2266
2267
2268
2269
2270
2271
More pages
2369
Next